Mardiza, Rosemalyn L.
HRN: 22-23-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/05/2025
05/12/2025
IV
500mg
Q8
T/c Obstructive Jaundice
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes